Patient guide

Cannabis for epilepsy in Kentucky

Kentucky includes intractable seizure disorders among qualifying conditions under KRS 218B. Epilepsy is the condition with the strongest published evidence for cannabis therapy — CBD is the star, and one CBD-based drug (Epidiolex) is FDA-approved for specific epilepsy syndromes. This page is educational; a neurologist has to be part of any epilepsy plan.

What it is

Epilepsy is a group of neurological conditions defined by recurrent seizures. Some patients respond well to anticonvulsants. Others — especially those with Dravet syndrome, Lennox-Gastaut, and other treatment-resistant syndromes — don't. Those patients are the population where cannabis evidence is strongest.

How cannabis may help

CBD reduces seizure frequency in several treatment-resistant epilepsy syndromes. The mechanism isn't fully mapped, but it doesn't rely on the intoxicating THC receptor. THC's role is more limited and, in some cases, may lower seizure threshold — which is why CBD-dominant products are the norm here. Neurologist supervision matters more than in any other qualifying condition.

Compounds

Cannabinoid profile to discuss

• CBD (high — the primary cannabinoid for seizure control)
• THC (very low, often <1:20 CBD:THC ratio)
• CBDV (early research; sometimes present in CBD-dominant cultivars)

Terpenes

Terpenes to consider

linalool — Anticonvulsant activity in preclinical research; calming.
myrcene — Sedating; may support seizure-associated sleep disruption.

Formats

Formats to consider

tincture — The standard for pediatric and adult epilepsy dosing. Precise mg control, no combustion.
edible — Long-acting coverage for patients with predictable seizure timing.

Questions to ask your budtender

• I need CBD-dominant. What's your highest CBD:THC ratio?
• Can you show me the COA — I need exact CBD mg per dose.
• Are any of your batches lab-verified for consistent CBD content across bottles?

Important

Cautions & interactions

Do not change your seizure medication without your neurologist. CBD interacts with clobazam, valproate, and other anticonvulsants — dosages may need adjustment. Bring COA printouts to neurology appointments so your team has hard numbers to work with.

homegrown, but with a plan

Track drops that match this profile

homegrown lets Kentucky patients save cannabinoid and terpene filters as Watches. When a cultivator publishes a new release that matches — say, a caryophyllene-forward 1:1 CBD:THC tincture — you get an email or push alert the day it hits shelves.

Create your patient account First dispensary visit

Educational information only. homegrown is not your practitioner. Kentucky's medical cannabis program requires registration under KRS Chapter 218B and a practitioner's written certification. Always discuss cannabis use with a licensed provider familiar with your full medication list.